Bayer Aktiengesellschaft (BUD:BAYER)

Hungary flag Hungary · Delayed Price · Currency is HUF
12,738
-38 (-0.30%)
At close: Dec 5, 2025
60.09%
Market Cap 12.50T
Revenue (ttm) 17.88T
Net Income (ttm) -77.21B
Shares Out n/a
EPS (ttm) -78.59
PE Ratio n/a
Forward PE 7.01
Dividend 44.63 (0.34%)
Ex-Dividend Date Apr 28, 2025
Volume 30
Average Volume 353
Open 12,860
Previous Close 12,776
Day's Range 12,738 - 12,860
52-Week Range 7,500 - 13,200
Beta n/a
RSI 66.81
Earnings Date Nov 12, 2025

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin... [Read more]

Industry Chemicals and Allied Products
Founded 1863
Employees 91,864
Stock Exchange Budapest Stock Exchange
Ticker Symbol BAYER
Full Company Profile

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.

Financial numbers in EUR Financial Statements

News

There is no news available yet.